科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/11/18 | 1,563 | 1,573 | 1,563 | 1,568 | +6 | +0.4% | 193,000 |
| 2013/11/15 | 1,560 | 1,570 | 1,558 | 1,562 | +1 | +0.1% | 317,000 |
| 2013/11/14 | 1,566 | 1,574 | 1,556 | 1,561 | -4 | -0.3% | 228,000 |
| 2013/11/13 | 1,570 | 1,574 | 1,558 | 1,565 | -5 | -0.3% | 208,000 |
| 2013/11/12 | 1,557 | 1,570 | 1,548 | 1,570 | +13 | +0.8% | 200,000 |
| 2013/11/11 | 1,547 | 1,558 | 1,541 | 1,557 | +19 | +1.2% | 274,000 |
| 2013/11/08 | 1,539 | 1,547 | 1,534 | 1,538 | -11 | -0.7% | 244,000 |
| 2013/11/07 | 1,547 | 1,554 | 1,539 | 1,549 | +12 | +0.8% | 273,000 |
| 2013/11/06 | 1,512 | 1,576 | 1,512 | 1,537 | +14 | +0.9% | 275,000 |
| 2013/11/05 | 1,526 | 1,532 | 1,513 | 1,523 | -5 | -0.3% | 242,000 |
| 2013/11/01 | 1,534 | 1,537 | 1,511 | 1,528 | -6 | -0.4% | 337,000 |
| 2013/10/31 | 1,540 | 1,543 | 1,528 | 1,534 | -6 | -0.4% | 267,000 |
| 2013/10/30 | 1,527 | 1,546 | 1,515 | 1,540 | +16 | +1% | 795,000 |
| 2013/10/29 | 1,524 | 1,533 | 1,510 | 1,524 | -1 | -0.1% | 260,000 |
| 2013/10/28 | 1,516 | 1,526 | 1,509 | 1,525 | +18 | +1.2% | 205,000 |
| 2013/10/25 | 1,523 | 1,523 | 1,500 | 1,507 | -16 | -1.1% | 290,000 |
| 2013/10/24 | 1,511 | 1,527 | 1,505 | 1,523 | +19 | +1.3% | 216,000 |
| 2013/10/23 | 1,512 | 1,533 | 1,504 | 1,504 | -26 | -1.7% | 384,000 |
| 2013/10/22 | 1,540 | 1,540 | 1,511 | 1,530 | -11 | -0.7% | 382,000 |
| 2013/10/21 | 1,516 | 1,542 | 1,515 | 1,541 | +13 | +0.9% | 207,000 |
| 2013/10/18 | 1,533 | 1,535 | 1,522 | 1,528 | ±0 | ±0% | 230,000 |
| 2013/10/17 | 1,508 | 1,528 | 1,507 | 1,528 | +21 | +1.4% | 250,000 |
| 2013/10/16 | 1,500 | 1,510 | 1,499 | 1,507 | +6 | +0.4% | 209,000 |
| 2013/10/15 | 1,492 | 1,504 | 1,487 | 1,501 | +16 | +1.1% | 336,000 |
| 2013/10/11 | 1,495 | 1,510 | 1,477 | 1,485 | -8 | -0.5% | 395,000 |
| 2013/10/10 | 1,469 | 1,493 | 1,469 | 1,493 | +26 | +1.8% | 299,000 |
| 2013/10/09 | 1,431 | 1,472 | 1,430 | 1,467 | +18 | +1.2% | 291,000 |
| 2013/10/08 | 1,450 | 1,457 | 1,426 | 1,449 | -13 | -0.9% | 358,000 |
| 2013/10/07 | 1,457 | 1,472 | 1,457 | 1,462 | +5 | +0.3% | 281,000 |
| 2013/10/04 | 1,466 | 1,468 | 1,442 | 1,457 | -18 | -1.2% | 337,000 |
| 2013/10/03 | 1,476 | 1,486 | 1,475 | 1,475 | -6 | -0.4% | 211,000 |
| 2013/10/02 | 1,500 | 1,500 | 1,478 | 1,481 | -17 | -1.1% | 234,000 |
| 2013/10/01 | 1,494 | 1,502 | 1,490 | 1,498 | +9 | +0.6% | 216,000 |
| 2013/09/30 | 1,491 | 1,494 | 1,481 | 1,489 | -2 | -0.1% | 215,000 |
| 2013/09/27 | 1,486 | 1,496 | 1,476 | 1,491 | +5 | +0.3% | 250,000 |
| 2013/09/26 | 1,491 | 1,491 | 1,475 | 1,486 | -14 | -0.9% | 217,000 |
| 2013/09/25 | 1,497 | 1,505 | 1,495 | 1,500 | +2 | +0.1% | 252,000 |
| 2013/09/24 | 1,495 | 1,513 | 1,495 | 1,498 | ±0 | ±0% | 287,000 |
| 2013/09/20 | 1,499 | 1,500 | 1,490 | 1,498 | +12 | +0.8% | 231,000 |
| 2013/09/19 | 1,479 | 1,491 | 1,472 | 1,486 | +9 | +0.6% | 346,000 |
| 2013/09/18 | 1,476 | 1,490 | 1,473 | 1,477 | +4 | +0.3% | 183,000 |
| 2013/09/17 | 1,483 | 1,492 | 1,473 | 1,473 | -9 | -0.6% | 252,000 |
| 2013/09/13 | 1,483 | 1,497 | 1,471 | 1,482 | -14 | -0.9% | 367,000 |
| 2013/09/12 | 1,501 | 1,502 | 1,482 | 1,496 | -5 | -0.3% | 220,000 |
| 2013/09/11 | 1,528 | 1,540 | 1,498 | 1,501 | -30 | -2% | 361,000 |
| 2013/09/10 | 1,535 | 1,545 | 1,523 | 1,531 | -4 | -0.3% | 179,000 |
| 2013/09/09 | 1,535 | 1,547 | 1,517 | 1,535 | +26 | +1.7% | 136,000 |
| 2013/09/06 | 1,543 | 1,544 | 1,506 | 1,509 | -18 | -1.2% | 191,000 |
| 2013/09/05 | 1,536 | 1,540 | 1,523 | 1,527 | -8 | -0.5% | 138,000 |
| 2013/09/04 | 1,520 | 1,540 | 1,520 | 1,535 | -5 | -0.3% | 129,000 |
2801～
2850
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 400,000円 | +30.5% | +111.0% | 4.75% | 11.27倍 | 0.98倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| サワイＧＨＤ | 199,600円 | +4.0% | +25.4% | 2.66% | 8.73倍 | 1.15倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 397,500円 | +3.6% | +6.1% | 3.02% | 13.83倍 | 0.81倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サンバイオ | 229,200円 | - | - | 0.00% | - | 106.16倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
